Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies by Ganzina, F, Pacciarini, M A, Di Pietro, N

Get full text

73 P - Oral idarubicin (OIDA) in elderly patients (pts) with acute myelogenous Leukemia (AML): An opportunity? by Visentin, F.C.A., Ganzina, F., Smeets, I., Biggi, M.

Get full text

Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology by Tamassia, V, Battaglia, A, Ganzina, F, Isetta, A M, Sacchetti, G, Cavalli, F, Goldhirsch, A, Brunner, K, Bernardo, G, Robustelli della Cuna, G

Get full text

Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer by LOPEZ, M, VICI, P, CARPANO, S, NATALI, M, GANZINA, F, MS CONTI, E, DI LAURO, L

Get full text

Phase II trial with oral idarubicin in advanced breast cancer by Lopez, M, Di Lauro, L, Papaldo, P, Lazzaro, B, Ganzina, F, Di Pietro, N

Get full text

Clinical evaluation of 4'-epi-doxorubicin in advanced solid tumors by Robustelli Della Cuna, G, Pavesi, L, Preti, P, Ganzina, F

Get full text

Controlled study of DTIC versus DTIC plus epirubicin in metastatic malignant melanoma by Lopez, M, Perno, C F, Di Lauro, L, Papaldo, P, Ganzina, F, Barduagni, A

Get full text

Phase II study of epirubicin in advanced malignant melanoma by Lopez, M, Perno, C F, Papaldo, P, Di Lauro, L, Ganzina, F, Barduagni, A

Get full text

Effect of quenching bath temperature on notch toughness of eutectoid steel with tempering at moderate temperatures by Ganzina, V. F., Sazonova, A. A., Surovtseva, T. E., Rebrina, A. A.

Get full text